- No public price. Enterprise contracts.
- Attested
- Type II
- —
- —
- US

Waystar
by Waystar · US
AI-powered healthcare payments platform for revenue cycle: eligibility, authorizations, claims, denials and patient payments (AltitudeAI).
On this page
- Regulatory & Compliance10/13.6
HIPAA + (SOC2 or BAA) attested
- Clinical Integration0/31.4
No EHR integrations listed
- Evidence Strength0/10
No peer-reviewed coverage
- Vendor & Market12/18
Top-tier funding and adoption
- Sentiment & Transparency3.3/15.5
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/4
No FDA clearance listed
- HIPAA / SOC2 / BAA10/10
HIPAA + (SOC2 or BAA) attested
- EHR integrations (count)0/18
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/8
None of the top-3 EHRs covered
- Bidirectional write-back0/5
No bidirectional write-back documented
- Peer-reviewed papers0/7
No peer-reviewed coverage
- RCT / meta-analysis / systematic review0/3
No RCT, meta-analysis, or systematic review
- Funding & adoption signal12/12
Top-tier funding and adoption
- Years in market0/6
Founded year not recorded
- Clinician sentiment (Reddit)0/9
No clinician sentiment data available
- Pricing transparency3/7
Pricing on request, no public amounts
Full RCM stack with 98.5% first-pass clean rate via AltitudeAI.
NASDAQ:WAY. Eligibility, claims, denials in one platform.
Bottom line
Waystar is an enterprise revenue-cycle platform for hospitals and large practices. It covers eligibility, prior authorization, claims, denials and patient payments, with AI added across the workflow. It has no public price. It suits a hospital finance team that wants one vendor for the front end and back end of billing.
What is Waystar and who sells it?
Waystar Holding Corp. was incorporated in Delaware in 2019, the year EQT and CPP Investments acquired it. It went public on Nasdaq in June 2024 under the ticker WAY and raised nearly $1 billion (SEC 10-K). The 10-K lists principal executive offices in Lehi, Utah, with an office in Louisville, Kentucky. In 2025 it agreed to buy Iodine Software for $1.25 billion, $625 million in cash plus shares, and the deal closed around 1 October 2025 (Fierce Healthcare).
What does it do?
The website calls it "an AI-powered healthcare payments software platform". The product list covers financial clearance, clinical integrity and revenue capture, claim and payer payment management, denial recovery and analytics. Specific functions include eligibility checks, estimates, authorizations, claim monitoring, remittance, patient payments and appeals. The AI layer is branded AltitudeAI and described as predictive, generative and agentic. Waystar claims to reach 60% of the US patient population and more than a million providers. Both claims are the vendor's.
What about security and integration?
The homepage shows HITRUST, SOC 2, PCI and HIPAA badges with no scope given, and no list of connected EHRs is published.
What does it cost?
There is no public price. It is an enterprise contract.
What do customers say?
The vendor cites a provider net promoter score of 74-plus from September 2023 on its homepage.
The verdict
Waystar fits a hospital revenue-cycle team that wants eligibility, claims, denials and payments from one vendor. Its Nasdaq listing means the 10-K describes the business, its offices and its acquisitions in filed detail. A buyer gets the price and the module-by-module security scope only through a sales quote.
Editorial review last generated October 15, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | — | — | No public price. Enterprise contracts. |
Source: vendor pricing page. Last checked October 15, 2026.
What deploys cleanly
Carries HITRUST (badge on waystar.com, scope not stated), SOC 2 (badge on waystar.com, scope not stated), PCI (badge on waystar.com), HIPAA (badge on waystar.com) per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.



